This presentation is delivered by GossamerBio, an industry partner of PHA Europe. They are in the process of developing a new PH medication that is based on a well-established component and is administered as an inhaled drug. During the presentation, Gossamer provides details about their drug and discusses their TORREY phase 2 study. The presentation concludes with an engaging Q&A session lasting almost 56 (!) minutes.
PAH (Pulmonary Arteriel Hypertension)
PH insights to current situation and the future
| Presenter: | Marc Humbert |
|---|---|
| Presentation date: | May 2025 |
| Length: | 30 minutes |
| Q&A: | Yes |
| Difficulty level (1-5): | 4 |
| Subtitled: | No |
| Dubbing: | No |
| Tag(s): | PAH, Treatment Options |
BAC Admin
April 19, 2026
